Hospira Logo (Nipent 01)
Nipent Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-0801
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nipent (NDC 0409-0801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula Pentostatin (Nipent 02)
Hospira Logo (Nipent 03)
Principal Display Panel (10 mg Vial Label)
Principal Display Panel (10 mg Vial Carton)
This text is a description of a cytotoxic drug called NIPENT, which is used for intravenous administration. Each vial of NIPENT contains 10 mg of pentostatin, which is a lyophilized powder that can be reconstituted with sterile water to yield a solution containing 2 mg/mL. The drug also contains Mannitol, USP, and sodium hydroxide and hydrochloric acid to adjust pH. The usual dosage and other relevant information can be obtained from the package insert. The drug should be stored at a temperature between 2° and 8°C (36° to 46°F), and should be kept out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
